Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 21

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

356

HTML

2279

Figures (1-2)

137

Tables (1-2)

160

Sum=2932

Jun 7, 2006 (publication date) through May 7, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Jun 7, 2006; 12(21): 3338-3343
Published online Jun 7, 2006. doi: 10.3748/wjg.v12.i21.3338

Figure 1 Correlation of serum fibrosis markers with histological staging (mean ± SD).

Figure 2 Correlation of serum fibrosis markers with histological staging (mean ± SD).

Citation: Lebensztejn DM, Sobaniec-Lotowska ME, Kaczmarski M, Voelker M, Schuppan D. Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha. World J Gastroenterol 2006; 12(21): 3338-3343
URL: https://www.wjgnet.com/1007-9327/full/v12/i21/3338.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i21.3338